10-Q

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

October 11, 2018

Period of Report

August 31, 2018

Accession Number

0001144204-18-053514

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →